IL6 and colorectal carcinoma: By integrating experimental and bioinformatic approaches, this study aims to define the prognostic value of IL-6 and RBP4 expression in CRC and to provide novel insights into their roles in colorectal tumorigenesis and potential as therapeutic targets.